Service & Software
Global Single Nucleotide Polymorphism (SNP) Genotyping Market Research Report 2025
- Aug 11, 25
- ID: 230842
- Pages: 110
- Figures: 104
- Views: 13
This report aims to provide a comprehensive presentation of the global market for Single Nucleotide Polymorphism (SNP) Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Nucleotide Polymorphism (SNP) Genotyping.
The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Nucleotide Polymorphism (SNP) Genotyping companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Segment by Type
Transversion
Transition
Segment by Application
Diagnostics
Animal
Plant
Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Nucleotide Polymorphism (SNP) Genotyping companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences
Segment by Type
Transversion
Transition
Segment by Application
Diagnostics
Animal
Plant
Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2020-2031)
2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region
2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Region (2020-2025)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2026-2031)
2.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2020-2025)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2020-2025)
3.2 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2024
3.5 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping Head office and Area Served
3.6 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Product and Application
3.7 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2020-2025)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2026-2031)
5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2020-2025)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.2.5 Affymetrix Recent Development
11.3 Applied Biosystems
11.3.1 Applied Biosystems Company Details
11.3.2 Applied Biosystems Business Overview
11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.3.5 Applied Biosystems Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.5.5 Beckman Coulter Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.8.5 Luminex Corporation Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.9.5 Enzo Life Sciences Recent Development
11.10 Bio-rad
11.10.1 Bio-rad Company Details
11.10.2 Bio-rad Business Overview
11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.10.5 Bio-rad Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.11.5 Sequenom Recent Development
11.12 Ocimum Biosolutions
11.12.1 Ocimum Biosolutions Company Details
11.12.2 Ocimum Biosolutions Business Overview
11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.12.5 Ocimum Biosolutions Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.13.5 GE Healthcare Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.14.5 GenScript Recent Development
11.15 Douglas Scientific
11.15.1 Douglas Scientific Company Details
11.15.2 Douglas Scientific Business Overview
11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.15.5 Douglas Scientific Recent Development
11.16 BGI
11.16.1 BGI Company Details
11.16.2 BGI Business Overview
11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.16.5 BGI Recent Development
11.17 Beijing Sunbiotech
11.17.1 Beijing Sunbiotech Company Details
11.17.2 Beijing Sunbiotech Business Overview
11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.17.5 Beijing Sunbiotech Recent Development
11.18 HuaGene Biotech
11.18.1 HuaGene Biotech Company Details
11.18.2 HuaGene Biotech Business Overview
11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.18.5 HuaGene Biotech Recent Development
11.19 Generay Biotech
11.19.1 Generay Biotech Company Details
11.19.2 Generay Biotech Business Overview
11.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.19.5 Generay Biotech Recent Development
11.20 Benegene
11.20.1 Benegene Company Details
11.20.2 Benegene Business Overview
11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.20.5 Benegene Recent Development
11.21 Shanghai Biochip
11.21.1 Shanghai Biochip Company Details
11.21.2 Shanghai Biochip Business Overview
11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.21.5 Shanghai Biochip Recent Development
11.22 GENESKY
11.22.1 GENESKY Company Details
11.22.2 GENESKY Business Overview
11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.22.5 GENESKY Recent Development
11.23 HD Biosciences
11.23.1 HD Biosciences Company Details
11.23.2 HD Biosciences Business Overview
11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.23.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transversion
1.2.3 Transition
1.3 Market by Application
1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostics
1.3.3 Animal
1.3.4 Plant
1.3.5 Research
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Perspective (2020-2031)
2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Growth Trends by Region
2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Region (2020-2025)
2.2.3 Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2026-2031)
2.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Dynamics
2.3.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
2.3.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
2.3.4 Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue
3.1.1 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Revenue (2020-2025)
3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Players (2020-2025)
3.2 Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single Nucleotide Polymorphism (SNP) Genotyping Revenue
3.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio
3.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2024
3.5 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping Head office and Area Served
3.6 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Product and Application
3.7 Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Type
4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Type (2020-2025)
4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2026-2031)
5 Single Nucleotide Polymorphism (SNP) Genotyping Breakdown Data by Application
5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size by Application (2020-2025)
5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
6.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
6.4 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
7.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
8.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025)
8.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
9.2 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
9.4 Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2020-2031)
10.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025)
10.4 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.1.4 Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.2.4 Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.2.5 Affymetrix Recent Development
11.3 Applied Biosystems
11.3.1 Applied Biosystems Company Details
11.3.2 Applied Biosystems Business Overview
11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.3.4 Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.3.5 Applied Biosystems Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.4.4 Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.5.4 Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.5.5 Beckman Coulter Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.6.4 Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.7.4 Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Details
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.8.4 Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.8.5 Luminex Corporation Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Details
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.9.4 Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.9.5 Enzo Life Sciences Recent Development
11.10 Bio-rad
11.10.1 Bio-rad Company Details
11.10.2 Bio-rad Business Overview
11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.10.4 Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.10.5 Bio-rad Recent Development
11.11 Sequenom
11.11.1 Sequenom Company Details
11.11.2 Sequenom Business Overview
11.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.11.4 Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.11.5 Sequenom Recent Development
11.12 Ocimum Biosolutions
11.12.1 Ocimum Biosolutions Company Details
11.12.2 Ocimum Biosolutions Business Overview
11.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.12.4 Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.12.5 Ocimum Biosolutions Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Details
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.13.4 GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.13.5 GE Healthcare Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.14.4 GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.14.5 GenScript Recent Development
11.15 Douglas Scientific
11.15.1 Douglas Scientific Company Details
11.15.2 Douglas Scientific Business Overview
11.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.15.4 Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.15.5 Douglas Scientific Recent Development
11.16 BGI
11.16.1 BGI Company Details
11.16.2 BGI Business Overview
11.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.16.4 BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.16.5 BGI Recent Development
11.17 Beijing Sunbiotech
11.17.1 Beijing Sunbiotech Company Details
11.17.2 Beijing Sunbiotech Business Overview
11.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.17.4 Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.17.5 Beijing Sunbiotech Recent Development
11.18 HuaGene Biotech
11.18.1 HuaGene Biotech Company Details
11.18.2 HuaGene Biotech Business Overview
11.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.18.4 HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.18.5 HuaGene Biotech Recent Development
11.19 Generay Biotech
11.19.1 Generay Biotech Company Details
11.19.2 Generay Biotech Business Overview
11.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.19.4 Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.19.5 Generay Biotech Recent Development
11.20 Benegene
11.20.1 Benegene Company Details
11.20.2 Benegene Business Overview
11.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.20.4 Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.20.5 Benegene Recent Development
11.21 Shanghai Biochip
11.21.1 Shanghai Biochip Company Details
11.21.2 Shanghai Biochip Business Overview
11.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.21.4 Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.21.5 Shanghai Biochip Recent Development
11.22 GENESKY
11.22.1 GENESKY Company Details
11.22.2 GENESKY Business Overview
11.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.22.4 GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.22.5 GENESKY Recent Development
11.23 HD Biosciences
11.23.1 HD Biosciences Company Details
11.23.2 HD Biosciences Business Overview
11.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Introduction
11.23.4 HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
11.23.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transversion
Table 3. Key Players of Transition
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2020-2025)
Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2026-2031)
Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2020-2025)
Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2024)
Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Headquarters and Area Served
Table 20. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Product and Application
Table 21. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2026-2031)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2026-2031)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 46. Illumina Company Details
Table 47. Illumina Business Overview
Table 48. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 49. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 50. Illumina Recent Development
Table 51. Affymetrix Company Details
Table 52. Affymetrix Business Overview
Table 53. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 54. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 55. Affymetrix Recent Development
Table 56. Applied Biosystems Company Details
Table 57. Applied Biosystems Business Overview
Table 58. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 59. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 60. Applied Biosystems Recent Development
Table 61. Agilent Technologies Company Details
Table 62. Agilent Technologies Business Overview
Table 63. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 64. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 65. Agilent Technologies Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 69. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 74. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 79. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Luminex Corporation Company Details
Table 82. Luminex Corporation Business Overview
Table 83. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 84. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 85. Luminex Corporation Recent Development
Table 86. Enzo Life Sciences Company Details
Table 87. Enzo Life Sciences Business Overview
Table 88. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 89. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 90. Enzo Life Sciences Recent Development
Table 91. Bio-rad Company Details
Table 92. Bio-rad Business Overview
Table 93. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 94. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 95. Bio-rad Recent Development
Table 96. Sequenom Company Details
Table 97. Sequenom Business Overview
Table 98. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 99. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 100. Sequenom Recent Development
Table 101. Ocimum Biosolutions Company Details
Table 102. Ocimum Biosolutions Business Overview
Table 103. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 104. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 105. Ocimum Biosolutions Recent Development
Table 106. GE Healthcare Company Details
Table 107. GE Healthcare Business Overview
Table 108. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 109. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 110. GE Healthcare Recent Development
Table 111. GenScript Company Details
Table 112. GenScript Business Overview
Table 113. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 114. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 115. GenScript Recent Development
Table 116. Douglas Scientific Company Details
Table 117. Douglas Scientific Business Overview
Table 118. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 119. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 120. Douglas Scientific Recent Development
Table 121. BGI Company Details
Table 122. BGI Business Overview
Table 123. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 124. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 125. BGI Recent Development
Table 126. Beijing Sunbiotech Company Details
Table 127. Beijing Sunbiotech Business Overview
Table 128. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 129. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 130. Beijing Sunbiotech Recent Development
Table 131. HuaGene Biotech Company Details
Table 132. HuaGene Biotech Business Overview
Table 133. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 134. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 135. HuaGene Biotech Recent Development
Table 136. Generay Biotech Company Details
Table 137. Generay Biotech Business Overview
Table 138. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 139. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 140. Generay Biotech Recent Development
Table 141. Benegene Company Details
Table 142. Benegene Business Overview
Table 143. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 144. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 145. Benegene Recent Development
Table 146. Shanghai Biochip Company Details
Table 147. Shanghai Biochip Business Overview
Table 148. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 149. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 150. Shanghai Biochip Recent Development
Table 151. GENESKY Company Details
Table 152. GENESKY Business Overview
Table 153. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 154. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 155. GENESKY Recent Development
Table 156. HD Biosciences Company Details
Table 157. HD Biosciences Business Overview
Table 158. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 159. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 160. HD Biosciences Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Picture
Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2024 VS 2031
Figure 4. Transversion Features
Figure 5. Transition Features
Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2024 VS 2031
Figure 8. Diagnostics Case Studies
Figure 9. Animal Case Studies
Figure 10. Plant Case Studies
Figure 11. Research Case Studies
Figure 12. Others Case Studies
Figure 13. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2024 VS 2031
Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2024
Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2024
Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 22. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 26. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2020-2031)
Figure 34. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 42. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 46. Israel Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 50. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 51. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 53. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 55. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 56. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 57. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 58. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 59. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 60. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 61. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 62. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 63. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 64. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 65. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 66. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 67. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 68. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 69. Shanghai Biochip Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 70. GENESKY Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 71. HD Biosciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transversion
Table 3. Key Players of Transition
Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2020-2025)
Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2026-2031)
Table 10. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends
Table 11. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
Table 12. Single Nucleotide Polymorphism (SNP) Genotyping Market Challenges
Table 13. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
Table 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players (2020-2025)
Table 16. Global Top Single Nucleotide Polymorphism (SNP) Genotyping Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Nucleotide Polymorphism (SNP) Genotyping as of 2024)
Table 17. Ranking of Global Top Single Nucleotide Polymorphism (SNP) Genotyping Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Headquarters and Area Served
Table 20. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Product and Application
Table 21. Global Key Players of Single Nucleotide Polymorphism (SNP) Genotyping, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2020-2025)
Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Type (2026-2031)
Table 27. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2020-2025)
Table 29. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2026-2031)
Table 31. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2026-2031) & (US$ Million)
Table 46. Illumina Company Details
Table 47. Illumina Business Overview
Table 48. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 49. Illumina Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 50. Illumina Recent Development
Table 51. Affymetrix Company Details
Table 52. Affymetrix Business Overview
Table 53. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 54. Affymetrix Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 55. Affymetrix Recent Development
Table 56. Applied Biosystems Company Details
Table 57. Applied Biosystems Business Overview
Table 58. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 59. Applied Biosystems Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 60. Applied Biosystems Recent Development
Table 61. Agilent Technologies Company Details
Table 62. Agilent Technologies Business Overview
Table 63. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 64. Agilent Technologies Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 65. Agilent Technologies Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 69. Beckman Coulter Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 74. Roche Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 79. Qiagen Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Luminex Corporation Company Details
Table 82. Luminex Corporation Business Overview
Table 83. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 84. Luminex Corporation Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 85. Luminex Corporation Recent Development
Table 86. Enzo Life Sciences Company Details
Table 87. Enzo Life Sciences Business Overview
Table 88. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 89. Enzo Life Sciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 90. Enzo Life Sciences Recent Development
Table 91. Bio-rad Company Details
Table 92. Bio-rad Business Overview
Table 93. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 94. Bio-rad Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 95. Bio-rad Recent Development
Table 96. Sequenom Company Details
Table 97. Sequenom Business Overview
Table 98. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 99. Sequenom Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 100. Sequenom Recent Development
Table 101. Ocimum Biosolutions Company Details
Table 102. Ocimum Biosolutions Business Overview
Table 103. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 104. Ocimum Biosolutions Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 105. Ocimum Biosolutions Recent Development
Table 106. GE Healthcare Company Details
Table 107. GE Healthcare Business Overview
Table 108. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 109. GE Healthcare Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 110. GE Healthcare Recent Development
Table 111. GenScript Company Details
Table 112. GenScript Business Overview
Table 113. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 114. GenScript Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 115. GenScript Recent Development
Table 116. Douglas Scientific Company Details
Table 117. Douglas Scientific Business Overview
Table 118. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 119. Douglas Scientific Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 120. Douglas Scientific Recent Development
Table 121. BGI Company Details
Table 122. BGI Business Overview
Table 123. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 124. BGI Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 125. BGI Recent Development
Table 126. Beijing Sunbiotech Company Details
Table 127. Beijing Sunbiotech Business Overview
Table 128. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 129. Beijing Sunbiotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 130. Beijing Sunbiotech Recent Development
Table 131. HuaGene Biotech Company Details
Table 132. HuaGene Biotech Business Overview
Table 133. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 134. HuaGene Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 135. HuaGene Biotech Recent Development
Table 136. Generay Biotech Company Details
Table 137. Generay Biotech Business Overview
Table 138. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 139. Generay Biotech Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 140. Generay Biotech Recent Development
Table 141. Benegene Company Details
Table 142. Benegene Business Overview
Table 143. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 144. Benegene Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 145. Benegene Recent Development
Table 146. Shanghai Biochip Company Details
Table 147. Shanghai Biochip Business Overview
Table 148. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 149. Shanghai Biochip Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 150. Shanghai Biochip Recent Development
Table 151. GENESKY Company Details
Table 152. GENESKY Business Overview
Table 153. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 154. GENESKY Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 155. GENESKY Recent Development
Table 156. HD Biosciences Company Details
Table 157. HD Biosciences Business Overview
Table 158. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product
Table 159. HD Biosciences Revenue in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025) & (US$ Million)
Table 160. HD Biosciences Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Single Nucleotide Polymorphism (SNP) Genotyping Picture
Figure 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type: 2024 VS 2031
Figure 4. Transversion Features
Figure 5. Transition Features
Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application: 2024 VS 2031
Figure 8. Diagnostics Case Studies
Figure 9. Animal Case Studies
Figure 10. Plant Case Studies
Figure 11. Research Case Studies
Figure 12. Others Case Studies
Figure 13. Single Nucleotide Polymorphism (SNP) Genotyping Report Years Considered
Figure 14. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2024 VS 2031
Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Players in 2024
Figure 18. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Single Nucleotide Polymorphism (SNP) Genotyping Revenue in 2024
Figure 20. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 22. United States Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 26. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2020-2031)
Figure 34. China Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 42. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2020-2031)
Figure 46. Israel Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Single Nucleotide Polymorphism (SNP) Genotyping Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Illumina Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 50. Affymetrix Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 51. Applied Biosystems Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 53. Beckman Coulter Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 55. Qiagen Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 56. Luminex Corporation Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 57. Enzo Life Sciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 58. Bio-rad Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 59. Sequenom Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 60. Ocimum Biosolutions Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 61. GE Healthcare Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 62. GenScript Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 63. Douglas Scientific Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 64. BGI Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 65. Beijing Sunbiotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 66. HuaGene Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 67. Generay Biotech Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 68. Benegene Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 69. Shanghai Biochip Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 70. GENESKY Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 71. HD Biosciences Revenue Growth Rate in Single Nucleotide Polymorphism (SNP) Genotyping Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232